Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

The combination therapy improved severe alopecia areata in a patient after 14 days.

JAK inhibitors might help treat alopecia areata.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Ruxolitinib cream may help treat severe hair loss in children.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

JAK inhibitors may help treat alopecia areata in children, but their safety needs careful evaluation.

Deucravacitinib helped a man regrow hair and improve psoriasis.

A skin rash after the AstraZeneca COVID-19 vaccine was treated successfully with medication.

Apremilast shows promise for several skin conditions but needs more research.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Dupilumab may help treat alopecia areata without needing high IgE levels.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.